FDA takes first action under new international collaboration with Australia and Canada
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for patients with rare type of lung disease
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
EMA/FDA analysis shows high degree of alignment in marketing application decisions between EU and US
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
"The threat of antimicrobial-resistant infections is a key challenge we face as a public health agency," said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D.
FDA approves first therapy for rare joint tumor
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first treatment for severe hypoglycemia that can be administered without an injection
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
FDA approves first generics of Lyrica
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA approves new treatment for refractory multiple myeloma
- FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
- FDA seeks public feedback on new drug approval transparency efforts
- FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
- FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer
- FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
- FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome